OPPM
Opus Point Partners Management’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-11,250
| Closed | -$489K | – | 61 |
|
|
2019
Q2 | $489K | Hold |
11,250
| – | – | 0.72% | 34 |
|
|
2019
Q1 | $428K | Hold |
11,250
| – | – | 0.58% | 42 |
|
|
2018
Q4 | $484K | Hold |
11,250
| – | – | 1.07% | 17 |
|
|
2018
Q3 | $553K | Sell |
11,250
-1,250
| -10% | -$61.4K | 1.32% | 24 |
|
|
2018
Q2 | $401K | Hold |
12,500
| – | – | 0.87% | 30 |
|
|
2018
Q1 | $389K | Sell |
12,500
-12,500
| -50% | -$389K | 0.76% | 30 |
|
|
2017
Q4 | $1.14M | Hold |
25,000
| – | – | 0.99% | 28 |
|
|
2017
Q3 | $939K | Hold |
25,000
| – | – | 0.84% | 32 |
|
|
2017
Q2 | $1.19M | Sell |
25,000
-25,000
| -50% | -$1.19M | 1.09% | 27 |
|
|
2017
Q1 | $2.28M | Hold |
50,000
| – | – | 1.69% | 25 |
|
|
2016
Q4 | $1.62M | Hold |
50,000
| – | – | 1.29% | 26 |
|
|
2016
Q3 | $1.71M | Buy |
+50,000
| New | +$1.71M | 0.96% | 26 |
|
|
2016
Q2 | – | Sell |
-35,110
| Closed | -$1.86M | – | 50 |
|
|
2016
Q1 | $1.86M | Buy |
35,110
+16,000
| +84% | +$848K | 1.44% | 25 |
|
|
2015
Q4 | $1.47M | Sell |
19,110
-1,890
| -9% | -$145K | 0.97% | 30 |
|
|
2015
Q3 | $863K | Sell |
21,000
-26,000
| -55% | -$1.07M | 0.48% | 32 |
|
|
2015
Q2 | $3.32M | Buy |
47,000
+12,051
| +34% | +$852K | 2.63% | 22 |
|
|
2015
Q1 | $3.11M | Buy |
+34,949
| New | +$3.11M | 2.6% | 20 |
|